A healthcare worker holds a vial of the Moderna COVID-19 Vaccine at a pop-up vaccination site operated by SOMOS Community Care during the coronavirus disease (COVID-19) pandemic in New York, January 29, 2021. Mike Segar | Reuters Moderna‘s Covid-19 vaccine was more than 90% effective at protecting against Covid-19 and more than 95% effective against… Read More »
Commuters’ sufferings continued on Tuesday due to a ban on public transports. Many of them walked to their workplaces and returned home on foot while the others shared autorickshaw, van or rickshaw rides. The streets of Dhaka’s Kakrail are busy on the second day of a week-long nationwide lockdown to curb the spread of coronavirus… Read More »
SINGAPORE — As parts of the world brace for a second wave of Covid-19 infections, the economic impact on Asia will likely be “limited” as the region will remain resilient, according to a Credit Suisse strategist. “I think clearly Asia is going to be resilient in the face of a second wave in developed markets… Read More »
US confirms its first case of COVID-19 reinfection: Healthy Nevada man, 25, contracted coronavirus twice in 48 days and had to be put on oxygen after getting SICKER during his second bout with the virus Man, 25, from the US, suffered fifth confirmed Covid-19 re-infection in the world He tested positive again 48 days after… Read More »
After Pfizer’s Ibrance failed a crucial study in HR-positive, HR-negative postsurgery breast cancer patients, the company clung to hope that it could still show a benefit in a high-risk subset of those patients. But new data have officially snuffed out those hopes. There’s “no saving adjuvant for Ibrance,” SVB Leerink analyst Geoffrey Porges wrote in… Read More »